Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lübbert

Showing results (71-80 of 248) with videos related to

Pageof 25
Sort By:
Blood|September 5, 2002
Severe cold hemagglutinin disease (CHD) successfully treated with rituximabMonika Engelhardt, Andreas Jakob, Björn Ruter, et al.
Leukemia Research|October 12, 2004
Nonclonal neutrophil responses after successful treatment of myelodysplasia with low-dose 5-aza-2'-deoxycytidine (decitabine)Michael Lübbert, Michael Daskalakis, Regina Kunzmann, et al.
European Journal of Haematology|October 9, 2002
Myelodysplastic syndrome in transformation to acute myeloid leukemia presenting with diabetes insipidus: due to pituitary infiltration association with abnormalities of chromosomes 3 and 7Claudia I Müller, Monika Engelhardt, Jörg Laubenberger, et al.
Journal of Leukocyte Biology|September 27, 2006
Inhibitors of DNA methylation and histone deacetylation independently relieve AML1/ETO-mediated lysozyme repressionRainer Claus, Manfred Fliegauf, Michael Stock, et al.
European Journal of Haematology|June 9, 2004
Hematologic and molecular spontaneous remission following sepsis in acute monoblastic leukemia with translocation (9;11): a case report and review of the literatureClaudia I Müller, Martin Trepel, Regina Kunzmann, et al.
British Journal of Haematology|April 15, 2011
Regulation of the adaptor molecule LAT2, an in vivo target gene of AML1/ETO (RUNX1/RUNX1T1), during myeloid differentiationJesús Duque-Afonso, Leticia Solari, Aitomi Essig, et al.
Journal of the American Academy of Dermatology|November 14, 2006
Bullous pemphigoid associated with hypereosinophilic syndrome: simultaneous response to imatinibSilke C Hofmann, Kristin Technau, Antonia M S Müller, et al.
Epigenetics|June 23, 2021
The epigenetics of breast cancer - Opportunities for diagnostics, risk stratification and therapyRieke Schröder, Anna-Lena Illert, Thalia Erbes, et al.
Leukemia Research|April 3, 2012
HDAC6 as a target for antileukemic drugs in acute myeloid leukemiaBjörn Hackanson, Leander Rimmele, Marco Benkißer, et al.
Cancers|May 30, 2020
Impact of the Injection Site on Growth Characteristics, Phenotype and Sensitivity towards Cytarabine of Twenty Acute Leukaemia Patient-Derived Xenograft ModelsJulia Schueler, Gabriele Greve, Dorothée Lenhard, et al.
Pageof 25

Showing results (71-80 of 248) with videos related to

Sort By:
Pageof 25
Blood|September 5, 2002
Severe cold hemagglutinin disease (CHD) successfully treated with rituximabMonika Engelhardt, Andreas Jakob, Björn Ruter, et al.
Leukemia Research|October 12, 2004
Nonclonal neutrophil responses after successful treatment of myelodysplasia with low-dose 5-aza-2'-deoxycytidine (decitabine)Michael Lübbert, Michael Daskalakis, Regina Kunzmann, et al.
European Journal of Haematology|October 9, 2002
Myelodysplastic syndrome in transformation to acute myeloid leukemia presenting with diabetes insipidus: due to pituitary infiltration association with abnormalities of chromosomes 3 and 7Claudia I Müller, Monika Engelhardt, Jörg Laubenberger, et al.
Journal of Leukocyte Biology|September 27, 2006
Inhibitors of DNA methylation and histone deacetylation independently relieve AML1/ETO-mediated lysozyme repressionRainer Claus, Manfred Fliegauf, Michael Stock, et al.
European Journal of Haematology|June 9, 2004
Hematologic and molecular spontaneous remission following sepsis in acute monoblastic leukemia with translocation (9;11): a case report and review of the literatureClaudia I Müller, Martin Trepel, Regina Kunzmann, et al.
British Journal of Haematology|April 15, 2011
Regulation of the adaptor molecule LAT2, an in vivo target gene of AML1/ETO (RUNX1/RUNX1T1), during myeloid differentiationJesús Duque-Afonso, Leticia Solari, Aitomi Essig, et al.
Journal of the American Academy of Dermatology|November 14, 2006
Bullous pemphigoid associated with hypereosinophilic syndrome: simultaneous response to imatinibSilke C Hofmann, Kristin Technau, Antonia M S Müller, et al.
Epigenetics|June 23, 2021
The epigenetics of breast cancer - Opportunities for diagnostics, risk stratification and therapyRieke Schröder, Anna-Lena Illert, Thalia Erbes, et al.
Leukemia Research|April 3, 2012
HDAC6 as a target for antileukemic drugs in acute myeloid leukemiaBjörn Hackanson, Leander Rimmele, Marco Benkißer, et al.
Cancers|May 30, 2020
Impact of the Injection Site on Growth Characteristics, Phenotype and Sensitivity towards Cytarabine of Twenty Acute Leukaemia Patient-Derived Xenograft ModelsJulia Schueler, Gabriele Greve, Dorothée Lenhard, et al.
Pageof 25